NOAH website
Compendium home page
Introduction
Presentation
Uses
Dosage and administration
Contra-indications, warnings, etc
Pharmaceutical precautions
Legal category
Packaging Quantities
Further information
Marketing authorisation number
Significant Changes
You are here:
Introduction
> Marketing authorisation number
Baycox Bovis 50 mg/ml oral suspension: Marketing authorisation number
Baycox Bovis 50 mg/ml oral suspension
Marketing authorisation number
Vm 00010/4144.
Date updated: 29 August 2007
Powered by the Librios Semantic Environment
Baycox Bovis 50 mg/ml oral suspension: Marketing authorisation number
Date updated: 29 August 2007